Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

CHEK vs NNOX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NNOX Wins Head-to-Head Institutional Verdict (4–0 across 6 Pillars · 2–4 Matrix Metrics)

NNOX Overall Winner 6-Pillar Tally: CHEK 0 – 4 NNOX (2 Tie) Matrix Metrics: CHEK 4 – 2 NNOX

As of Nov 20, 2026, NANO-X IMAGING LTD (NNOX) is the stronger overall head-to-head candidate over Check-Cap Ltd. (CHEK) in the Tradestie Institutional Equity Comparison Engine, winning 2–4 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CHEK carries a Unified Composite Score of 52.1/100 (HOLD) at $1.61 (N/M Forward P/E, 0.0% operating margin), whereas NNOX carries 45.0/100 (HOLD) at $0.23 (N/M Forward P/E, -392.7% operating margin).

  • Composite vs. Pillar Nuance: While CHEK currently prints a higher short-term Unified Composite Score (52.1/100 HOLD vs. NNOX 45.0/100 HOLD), NNOX captures the overall institutional head-to-head verdict (2–4 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (-392.7% vs. 0.0% operating margin) and revenue trajectory (+36.7% vs. +0.0% YoY).
  • Technical & Structure Timing Caution: CHEK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 51.0); meanwhile NNOX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 30.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CHEK vs NNOX
CHEK NASDAQ
Check-Cap Ltd.
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
$1.61
+1.9% 1D
Market Cap $9.2M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.94β · 179% Vol
Unified Composite Score
52.1 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 51
RSI-14: 51.0 · SMA20: $1.52 · SMA50: $1.80
NNOX NASDAQ Head-to-Head Winner
NANO-X IMAGING LTD Ordinary Shares
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
$0.23
-2.17% 1D
Market Cap $18.1M
TTM Revenue $16M
Forward P/E N/M
Beta / 30D Vol 1.08β · 233% Vol
Unified Composite Score
45.0 / 100 HOLD
Tech 33.0 Fund 57.0 Flow 71.0 Mom 74.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -31.5%), weak momentum, RSI 30
RSI-14: 30.2 · SMA20: $0.30 · SMA50: $0.47

6-Pillar Scorecard Institutional Category Breakdown (CHEK 0 – 4 NNOX)

Columns: Metric · CHEK · NNOX
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale NNOX
Revenue Growth (YoY) +0.0% +36.7%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) N/A $16M
Market Cap $9.2M $18.1M
3. Profitability & Quality NNOX
Gross Margin N/A -77.2%
Operating Margin 0.0% -392.7%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) -226.2% -99.0%
4. Balance Sheet & Cash Flow NNOX
Cash Generation (TTM) N/A -$50M EBITDA
Cash Flow Margin N/A N/A
Net Cash / Leverage -226.2% ROE $23M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning NNOX
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) 0.0% (<1st %ile)
Put/Call OI Skew N/A 0.04x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral ACCUMULATION · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role X-Ray Apparatus & Tubes & Related Irradiation Apparatus Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CHEK (4) vs NNOX (2)
Institutional Metric CHEK NNOX Criterion Row Edge
Market Capitalization
Scale
$9.2M $18.1M Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+0.0% +36.7% Higher Growth NNOX
Operating Margin (TTM)
Profitability
0.0% -392.7% Higher Margin CHEK
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
-226.2% -99.0% Higher ROE NNOX
52-Week Range Position
Momentum
41% ($1–$3) 0% ($0–$5) Stronger Trend CHEK
Beta / 30D Volatility
Risk Regime
0.94β · 179% Vol 1.08β · 233% Vol Lower Realized Risk CHEK
Unified Institutional Score
Composite Signal
52.1 / 100 (HOLD) 45.0 / 100 (HOLD) Higher Composite CHEK
Trailing 12M Revenue (USD)
Operating Scale
N/A $16M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A -77.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (-226.2% ROE) -$50M EBITDA ($23M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NNOX +39.14 pp
CHEK: +11.03% · NNOX: +50.17%
3M Horizon NNOX +39.14 pp
CHEK: +11.03% · NNOX: +50.17%
6M Horizon NNOX +39.14 pp
CHEK: +11.03% · NNOX: +50.17%
1Y Horizon NNOX +39.14 pp
CHEK: +11.03% · NNOX: +50.17%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CHEK vs NNOX. Trailing 12-month operating profitability (CHEK 0.0% vs NNOX -392.7%) and valuation multiples (CHEK N/M vs NNOX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CHEK ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-226.2% · N/M
NNOX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$16M
Gross Margin-77.2%
Op. Margin-392.7%
ROE / Fwd P/E-99.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CHEK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CHEK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NNOX BREAKDOWN
95d in phase · OBV ACCUMULATION
Current IV 0.0%
IV Percentile <1st %ile
Put/Call OI Skew 0.04x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact NNOX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CHEK Moat Profile Cyclical / Execution-Driven Positioning
X-Ray Apparatus & Tubes & Related Irradiation Apparatus Operator
Competes within the X-Ray Apparatus & Tubes & Related Irradiation Apparatus value chain with $9.2M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
NNOX Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $18.1M market capitalization and -392.7% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CHEK vs NNOX Key Questions & Quantitative Answers

As of Nov 20, 2026, NANO-X IMAGING LTD (NNOX) is the stronger overall head-to-head candidate over Check-Cap Ltd. (CHEK) in the Tradestie Institutional Equity Comparison Engine, winning 2–4 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CHEK carries a Unified Composite Score of 52.1/100 (HOLD) at $1.61 (N/M Forward P/E, 0.0% operating margin), whereas NNOX carries 45.0/100 (HOLD) at $0.23 (N/M Forward P/E, -392.7% operating margin). Composite vs. Pillar Nuance: While CHEK currently prints a higher short-term Unified Composite Score (52.1/100 HOLD vs. NNOX 45.0/100 HOLD), NNOX captures the overall institutional head-to-head verdict (2–4 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (-392.7% vs. 0.0% operating margin) and revenue trajectory (+36.7% vs. +0.0% YoY). Technical & Structure Timing Caution: CHEK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 51.0); meanwhile NNOX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 30.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

NNOX leads the Growth & Scale pillar: CHEK posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with NNOX at +36.7% YoY revenue growth and +0.0% YoY earnings growth on $16M TTM revenue (-77.2% gross margin, -392.7% operating margin). On trailing 12-month operating scale, CHEK generates N/A in USD-normalized revenue versus $16M for NNOX. In operating R&D and SG&A reinvestment, CHEK deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for NNOX.

CHEK and NNOX trade at balanced relative valuation multiples. CHEK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas NNOX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CHEK (-226.2% ROE) versus NNOX (-99.0% ROE) capital efficiency.

In options market volatility and institutional positioning, CHEK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.94β · 179% Vol realized risk). By comparison, NNOX carries 0.0% implied volatility (<1st %ile, Compressed (<25th %ile)), a 0.04x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.08β · 233% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.